BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 14967437)

  • 1. Initiation of a teleradiotherapeutic network for patients in German lymphoma studies.
    Eich HT; Müller RP; Schneeweiss A; Hansemann K; Semrau R; Willich N; Rübe C; Sehlen S; Hinkelbein M; Diehl V
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):805-8. PubMed ID: 14967437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group.
    Eich HT; Engenhart-Cabillic R; Hansemann K; Lukas P; Schneeweiss A; Seegenschmiedt H; Skripnitchenko R; Staar S; Willich N; Müller RP
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1419-24. PubMed ID: 18234433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas].
    Eich HT; Schneeweiss A; Skripnitchenko R; Hansemann K; Gossmann A; Müller RP
    Rontgenpraxis; 2007; 56(4):145-51. PubMed ID: 17390954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The radiotherapy reference panel--experiences and results of the German Hodgkin Study Group (GHSG).
    Eich HT; Müller RP
    Eur J Haematol Suppl; 2005 Jul; (66):98-105. PubMed ID: 16007876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial experience with the quality assurance program of radiation therapy on behalf of Japan Radiation Oncology Group (JAROG).
    Isobe K; Kagami Y; Higuchi K; Kodaira T; Hasegawa M; Shikama N; Nakazawa M; Fukuda I; Nihei K; Ito K; Teshima T; Oguchi M;
    Jpn J Clin Oncol; 2007 Feb; 37(2):135-9. PubMed ID: 17255160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radiotherapeutic quality assurance in the Hodgkin's disease study HD4 supported by the BMFT (Bundesministerium für Forschung und Technologie)].
    Roth SL; Dühmke E; Kirschner H; Willich N; Müller RP; Bleher A; Pfreundschuh M; Löffler M; Diehl V
    Strahlenther Onkol; 1990 Sep; 166(9):584-7. PubMed ID: 2120784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy for lymphoma involving the mediastinum.
    Goodman KA; Toner S; Hunt M; Wu EJ; Yahalom J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):198-206. PubMed ID: 15850922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stop the pain! A nation-wide quality improvement programme in paediatric oncology pain control.
    Zernikow B; Hasan C; Hechler T; Huebner B; Gordon D; Michel E
    Eur J Pain; 2008 Oct; 12(7):819-33. PubMed ID: 18222100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile of European radiotherapy departments contributing to the EORTC Radiation Oncology Group (ROG) in the 21st century.
    Budiharto T; Musat E; Poortmans P; Hurkmans C; Monti A; Bar-Deroma R; Bernstein Z; Tienhoven Gv; Collette L; Duclos F; Davis B; Aird E;
    Radiother Oncol; 2008 Sep; 88(3):403-10. PubMed ID: 18538427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric radiation oncology in Germany: a study of availability and application.
    Bölling T; Ernst I; Könemann S; Willich N
    Klin Padiatr; 2008; 220(3):178-82. PubMed ID: 18478491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A scenario for a web-based radiation treatment planning structure: A new tool for quality assurance procedure?
    Kouloulias VE; Ntasis E; Poortmans P; Maniatis TA; Nikita KS
    Technol Health Care; 2003; 11(2):105-14. PubMed ID: 12697952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of involved field radiotherapy in the HD 13 and HD 14 trials : Report of the radiotherapy panel of the German Hodgkin Study Group (GHSG).
    Kriz J; Baues C; Engenhart-Cabillic R; Haverkamp U; Herfart K; Lukas P; Plütschow A; Schmidberger H; Staar S; Fuchs M; Engert A; Eich HT
    Strahlenther Onkol; 2017 Feb; 193(2):109-115. PubMed ID: 27596217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.
    Eich HT; Haverkamp U; Engert A; Kocher M; Skripnitchenko R; Brillant C; Sehlen S; Dühmke E; Diehl V; Müller RP
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):860-5. PubMed ID: 15925455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations in the use of portal images].
    Garcia R; Bodez V; Vial L; Le Thanh H; Reboul F
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S56-60. PubMed ID: 15679248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EORTC Radiation Oncology Group quality assurance platform: establishment of a digital central review facility.
    Fairchild A; Aird E; Fenton PA; Gregoire V; Gulyban A; Lacombe D; Matzinger O; Poortmans P; Ruyskart P; Weber DC; Hurkmans CW
    Radiother Oncol; 2012 Jun; 103(3):279-86. PubMed ID: 22633815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Improvement in stroke care in a non-urban community hospital--quality of procedures before and after participating in a telemedical stroke network].
    Müller H; Nimmrichter B; Schenkel J; Schneider HL; Haberl RL; Audebert HJ
    Dtsch Med Wochenschr; 2006 Jun; 131(23):1309-14. PubMed ID: 16761199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.
    Chera BS; Rodriguez C; Morris CG; Louis D; Yeung D; Li Z; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1173-80. PubMed ID: 19386423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.